FORE's Team Links Team Board of Directors

Medical and Scientific Advisory Board

Claude Arnaud, MD
Claude D. Arnaud is Emeritus Professor of Medicine and Physiology at the University of California, San Francisco. He is currently Chief Medical Officer and Chairman of the Scientific Advisory Board of Imaging Therapeutics Inc., a new biotechnology company located Redwood City, California. Dr. Arnaud is internationally recognized for his research in bone and mineral metabolism. It was his original cilincal trial that directly inspired Lilly to commercialize hPTH (1-34) for the treatment of osteoporosis, and he was a prominant co-author of the manuscript that led to Forteo’s FDA registration. Dr. Arnaud’s most recent research is in developing a highly specific and sensitive, computer based technology to predict fragility hip fractures, which will provide a noninvasive, widely available, inexpensive yet, sophistated and highly effective tool to accurately assess osteoporosis prognosis.

Dr. Arnaud was one of the six founders of the American Society for Bone and Mineral Research (ASBMR).  He was also founder and Chief of the Endocrine Units at the Mayo Medical School and the San Francisco VA Medical Center as well as the UCSF Program in Bone Biology and Osteoporosis. While at UCSF, Dr Arnaud’s research was continuously funded simultaneously by the National Institutes of Health for 30 years, the National Aeronautics and Space Administration for 15 years and the Veterans Administration for 10 years. He has authored more than 300 scientific papers.

  Bruce Ettinger, MD
After graduating cum laude from Harvard Medical School, Dr. Ettinger completed his medical residency on the Harvard service of the Boston City Hospital. He then served a fellowship in Endocrinology and Metabolism at the Metabolic Research Unit of the University of California, San Francisco. He has spent 30 years practicing endocrinology and internal medicine. He is past President of the North American Menopause Society. Dr. Ettinger has authored or co-authored over 137 peer-reviewed scientific publications, and has written numerous book chapters. Dr. Ettinger’s current research interests include: osteoporosis, kidney stones and calcium metabolism, estrogens and other female hormone therapies, menopause, and pharmaco-epidemiology.


Betsy McClung, MN RN
Betsy McClung is the Associate Director for the Oregon Osteoporosis Center in Portland, Oregon.  She has been involved in the clinical evaluation and treatment of patients at risk or diagnosed with osteoporosis for more than 20 years in collaboration with Michael McClung, MD, the Center’s Director.  Ms. McClung  continues to be active in professional educational activities at the local, national and international level. Ms. McClung is a member of the Endocrine Nurses Society and is a past president of this society.  She is also a member of The North American Menopause Society and has served on the Society’s Executive Board of Trustees.  She is a member of the American Society for Bone and Mineral Research. She currently serves on the Board of Directors for The Paget Foundation as well as the Scientific Advisory Board for the FORE. Ms McClung is the author of numerous papers and book chapters on postmenopausal women’s health with a specific focus on osteoporosis evaluation and management.

Michael McClung, MD
Dr. McClung graduated from Rice University in Houston and from the University of Texas Southwestern Medical School in Dallas. After his training in Internal Medicine at Parkland Hospital in Dallas, he completed a fellowship in Endocrinology at the National Institute of Health in Bethesda, Maryland. He then joined the faculty at the Oregon Health Sciences University, where he is an Associate Professor of Medicine. At OHSU, he founded a clinic devoted to the care of patients with disorders of bone and calcium metabolism that eventually grew into the Oregon Osteoporosis Center. In 1987, Dr. McClung joined the Department of Medical Education at Providence Medical Center where he is actively involved in the training of young physicians. He is board certified in both Internal Medicine and in Endocrinology and Metabolism and is a fellow of the American College of Endocrinologists.

Dolores Shoback, MD
Dolores Shoback sees general endocrine patients with an emphasis on metabolic bone disease and osteoporosis. She is board certified in internal medicine with a subspecialty in endocrinology and metabolism. A professor of medicine and director of the UCSF Training Program in Diabetes, Endocrinology and Metabolism, her research interests are metabolic bone disease, the calcium sensing receptor and parathyroid hormone. Shoback completed her undergraduate studies at the University of Pennsylvania. She went on to Johns Hopkins University for medical school and performed a residency in internal medicine at Johns Hopkins Hospital and then completed a fellowship in endocrinology at Brigham and Woman's Hospital in Boston.

Frederick Singer, MD
Dr. Singer taught at Harvard Medical School prior to assuming faculty positions at both USC's and UCLA's schools of medicine. He has served on several advisory committees for the U.S. Public Health Service, co-chaired medical symposia on bone disorders, and received a special award from the Paget's Disease Foundation. Before joining JWCI, Dr. Singer was director of the Bone Center at Cedars-Sinai Medical Center (Los Angeles). As Director of the Endocrine/Bone Disease Program at JWCI, Dr. Singer is expanding his investigations of abnormal bone metabolism in cancer patients.

Nancy Woods, PhD RN FAAN
Nancy Fugate Woods, is dean of the School of Nursing and professor in the department of family and child nursing at the University of Washington. Since the late 1970s, she has led a sustained program of research in the field of women’s health. Her collaborative research has resulted in an improved understanding of women’s transition to menopause, including physical and emotional factors; has advanced nursing care for mid-life women; and has provided women with a better understanding of their health. Her honors include election to the Institute of Medicine of the National Academies and to the American Academy of Nursing. She received the American Nurses Foundation Distinguished Contribution to Nursing Research Award, and the Pathfinder Award from the Friends of the National Institute for Nursing Research. She earned a B.S. in nursing from the University of Wisconsin, Eau Claire, in 1968; a M.N. from the University of Washington in 1969; and a Ph.D. in epidemiology from the University of North Carolina, Chapel Hill, in 1978.

MEDICAL CONSULTANTS
Aruna Chakravorty, MD, PhD, CCD
Risa Kagan, MD, CCD
Alfred Petrocelli, MD, CCD

LIMITED LICENSE SCHOOL STAFF
Beverley Tracewell, RN - Program Director
Jerry Hollister, RT - Program Manager

LIMITED LICENSE SCHOOL FACULTY ADVISORS
John Shepherd, PhD
Jennifer Yates, PhD
Mary Oates, MD
David Oates MD

LIMITED LICENSE SCHOOL RADIOLOGY SUPERVISOR OPERATORS
Aruna Chakravorty, MD, PhD, CCD
Joan Lo, MD, CCD
Roy Harris, MD, CCD
Mary Oates, MD, CCD
David Oates, MD, CCD

LIMITED LICENSE SCHOOL CLINICAL INSTRUCTORS
Beverley Tracewell, RN
Jerry Hollister, RT
Kyla Kent, CCT
Karen Felts, CCT
Micah Wendell, CDT